Posts in category

In Depth


Debbie Rigby rounds up the latest in research news Ozempic v Mounjaro: what is the difference between semaglutide and tirzepatide? Glucagon-like peptide-1 (GLP-1) agonists are a second line treatment for …

Capital Gains Tax is one of those concepts business owners and investors know about but don’t always fully understand, writes Priya Narsing, a director at Peak Strategies.   It can have …

Pharmacists can offer knowledge, education and support to empower women and improve their quality of life through menopause and beyond, writes Leanne Philpott Key points The average age of menopause …

Interest rate relief is great, but it doesn’t touch the sides of the cost-of-living crisis… and if you’re renting, it’s unlikely to make much difference at all, writes Guild national …

World events drew much of our attention in 1915, but pharmacists still took the time to point out one enduring bugbear: their medical colleagues’ handwriting The Australasian Journal of Pharmacy …

Debbie Rigby rounds up the latest in research news Ferric carboxymaltose for anemia in late pregnancy A randomized controlled trial has demonstrated that intravenous ferric carboxymaltose effectively and safely reduces …

Chemist Warehouse’s merger with Sigma Healthcare poses big questions for pharmacy owners and rival banner groups, John Thornett of Peak Strategies says  There is no doubt the Chemist Warehouse model …

The return to school should be an exciting time for students, but it can also mean a higher risk of asthma flare-ups, writes Leanne Philpott Key points: Around 8% of …

The Sixties are in full swing and it’s good news all around in pharmacy, as members of the profession stand ready for the metric system In February 1965, the Australasian …

‘Be curious, be proactive,’ says Mitch, an ECP working on the NSW Pharmacy Trial, and the first pharmacist recognised through the ANZCAP independent pathway Mitchell Budden currently works as a …

Debbie Rigby rounds up the latest in research news Association and mechanism of montelukast on sleep disorders US data suggests a higher prevalence of sleep disorders (25.28%) inpatients prescribed montelukast. …

There are at least six key areas to focus on to help make a fresh, optimistic start to the new year for your pharmacy, says Rebecca Goodsell of Peak Strategies …